ATE331537T1 - Topisch anwendbare arzneimittelformulierung - Google Patents

Topisch anwendbare arzneimittelformulierung

Info

Publication number
ATE331537T1
ATE331537T1 AT02747591T AT02747591T ATE331537T1 AT E331537 T1 ATE331537 T1 AT E331537T1 AT 02747591 T AT02747591 T AT 02747591T AT 02747591 T AT02747591 T AT 02747591T AT E331537 T1 ATE331537 T1 AT E331537T1
Authority
AT
Austria
Prior art keywords
topically applicable
medicinal formulation
applicable medicinal
formulation
topically
Prior art date
Application number
AT02747591T
Other languages
English (en)
Inventor
Alvin Berlat
Original Assignee
Advanced Biotechnologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Biotechnologies filed Critical Advanced Biotechnologies
Application granted granted Critical
Publication of ATE331537T1 publication Critical patent/ATE331537T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02747591T 2001-07-24 2002-07-23 Topisch anwendbare arzneimittelformulierung ATE331537T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30754801P 2001-07-24 2001-07-24

Publications (1)

Publication Number Publication Date
ATE331537T1 true ATE331537T1 (de) 2006-07-15

Family

ID=23190223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02747591T ATE331537T1 (de) 2001-07-24 2002-07-23 Topisch anwendbare arzneimittelformulierung

Country Status (21)

Country Link
US (1) US8263114B2 (de)
EP (1) EP1409034B1 (de)
JP (1) JP3778559B2 (de)
KR (1) KR101009267B1 (de)
CN (1) CN1234426C (de)
AT (1) ATE331537T1 (de)
AU (1) AU2002317981B2 (de)
BR (1) BRPI0211282B8 (de)
CA (1) CA2454673C (de)
DE (1) DE60212847T2 (de)
DK (1) DK1409034T3 (de)
ES (1) ES2268061T3 (de)
HK (1) HK1061362A1 (de)
IL (2) IL160109A0 (de)
MX (1) MXPA04000444A (de)
NO (1) NO334175B1 (de)
NZ (1) NZ529957A (de)
PT (1) PT1409034E (de)
RU (1) RU2306121C2 (de)
WO (1) WO2003009877A1 (de)
ZA (1) ZA200400488B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070237834A1 (en) * 2003-04-18 2007-10-11 Bioderm Research Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
WO2005003032A1 (en) * 2003-07-03 2005-01-13 The University Court Of The University Of St Andrews Zeolites for delivery of nitric oxide
MX2007005476A (es) * 2004-11-07 2008-04-22 Cupron Corp Materiales que contienen cobre para tratar heridas, quemaduras y otras condiciones de la piel.
CA2637447A1 (en) * 2006-01-30 2007-08-02 Sanjeev Kaila A composition including a silicone-based polymer and a method of treating skin disorders using the composition
EP2168407B1 (de) * 2007-06-29 2013-10-23 Carmanah Technologies Corp. Intelligentes flächenbeleuchtungssystem
UA28103U (uk) * 2007-07-12 2007-11-26 Ольга Олександрівна Біляєва Комплексний сорбційно-протеолітичний препарат сертасил для лікування гнійних ран, трофічних виразок, опіків
GB0821345D0 (en) 2008-11-21 2008-12-31 P Q Silicas Uk Ltd Composition and dressing with nitric oxide
WO2010079209A2 (en) * 2009-01-08 2010-07-15 Golub Alexandr A Compositions for treating wounds and skin conditions
US20100322875A1 (en) * 2009-06-18 2010-12-23 Advanced Bio-Technologies, Inc. Silicone scar treatment preparation
JP2012533568A (ja) * 2009-07-17 2012-12-27 ケアフュージョン２２００、インコーポレイテッド 抗菌物質を包含する粒子
RU2429820C2 (ru) * 2009-09-24 2011-09-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" (ЗАО"ИПН") Антисептическая мазь наружного применения (2 варианта)
HUE057866T2 (hu) 2009-11-03 2022-06-28 Lipidor Ab Lipid réteget képzõ kompozíció egy élõ organizmus felületére történõ alkalmazásra
WO2011056116A1 (en) * 2009-11-03 2011-05-12 Lipidor Ab Composition for promoting wound healing
CA2802884C (en) * 2010-06-17 2020-02-25 Covalon Technologies Inc. Antimicrobial silicone-based wound dressings
WO2012150890A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Antibacterial composition
US20130144225A1 (en) 2011-12-06 2013-06-06 Jessica Rowen Method And Device For Scar Management
TWI474823B (zh) * 2013-09-25 2015-03-01 Far Eastern New Century Corp 疤痕凝膠的組成物
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
CN106729963A (zh) * 2016-12-22 2017-05-31 苏州迈达医疗器械有限公司 一种硅酮凝胶敷料及其生产工艺
US10496949B2 (en) 2017-01-04 2019-12-03 Christopher Zoumalan Compositions and methods for treating cutaneous conditions
RU2674445C1 (ru) * 2017-12-11 2018-12-10 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия имени С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Спрей для наружного применения спиртовой
CN108714141A (zh) * 2018-05-29 2018-10-30 南京华开生物科技有限公司 硅酮疤痕喷剂
WO2020019050A1 (en) * 2018-07-26 2020-01-30 Exciton Pharma Corp. Vehicles and delivery systems for oxidizing agents
WO2020061671A1 (en) * 2018-09-26 2020-04-02 Exaltexx Inc. Winterized maturing agent, viscosity reducer and production enhancer
US11433016B2 (en) 2019-03-28 2022-09-06 L'oreal Cosmetic compositions for skin
US11364190B2 (en) 2019-07-30 2022-06-21 L'oreal Acid perfluoro-free self-foaming facial cleanser composition
US11207255B2 (en) 2019-07-30 2021-12-28 L'oreal Perfluoro-free self-foaming facial cleanser composition
US11213473B1 (en) 2020-09-18 2022-01-04 Christopher Zoumalan Skin brightening composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0618899B2 (ja) * 1987-06-30 1994-03-16 品川燃料株式会社 抗菌性ゼオライト含有フィルム
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
JPH049327A (ja) 1990-04-04 1992-01-14 Kootec Kk 創傷被覆材
FR2678513B1 (fr) * 1991-07-03 1995-06-30 Laboratoires Hygiene Dietetique Pansement cicatrisant.
US6258995B1 (en) 1995-07-19 2001-07-10 Advanced Medical Solutions Limited Wound treatment composition
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
JPH09194350A (ja) 1996-01-19 1997-07-29 Morishita Jintan Kk 創傷被覆材
US6231259B1 (en) * 1996-07-26 2001-05-15 The Gillette Company Viscous product dispenser with porous dome
US5741509A (en) * 1996-08-26 1998-04-21 Alvin S. Berlat Silicone wound dressing
AU1923199A (en) * 1997-12-17 1999-07-05 Hemodynamics, Inc. Sealing media for surgery and wound closure
JP2002536397A (ja) 1999-02-12 2002-10-29 ザ、プロクター、エンド、ギャンブル、カンパニー 皮膚消毒剤組成物
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
GB0007140D0 (en) * 1999-09-27 2000-05-17 Dow Corning Sa Scar treatment composition
CN1443062A (zh) * 2000-05-23 2003-09-17 荷兰联合利华有限公司 除臭剂和/或防汗剂组合物
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
US8563604B2 (en) * 2007-09-30 2013-10-22 Valeant Pharmaceuticals International Silicone gel-based compositions for wound healing and scar reduction

Also Published As

Publication number Publication date
KR20040032864A (ko) 2004-04-17
IL160109A (en) 2008-04-13
RU2004105164A (ru) 2005-06-27
NZ529957A (en) 2005-11-25
NO334175B1 (no) 2014-01-06
PT1409034E (pt) 2006-11-30
EP1409034A1 (de) 2004-04-21
CA2454673A1 (en) 2003-02-06
DE60212847T2 (de) 2007-06-14
DE60212847D1 (de) 2006-08-10
IL160109A0 (en) 2004-06-20
US8263114B2 (en) 2012-09-11
BR0211282A (pt) 2004-08-03
ES2268061T3 (es) 2007-03-16
DK1409034T3 (da) 2006-10-30
MXPA04000444A (es) 2004-10-27
JP3778559B2 (ja) 2006-05-24
JP2005502639A (ja) 2005-01-27
RU2306121C2 (ru) 2007-09-20
AU2002317981B2 (en) 2006-12-07
CA2454673C (en) 2011-04-26
EP1409034B1 (de) 2006-06-28
CN1527729A (zh) 2004-09-08
KR101009267B1 (ko) 2011-01-18
ZA200400488B (en) 2005-06-29
BRPI0211282B8 (pt) 2021-05-25
WO2003009877A1 (en) 2003-02-06
NO20040319L (no) 2004-01-23
HK1061362A1 (en) 2004-09-17
CN1234426C (zh) 2006-01-04
BR0211282B1 (pt) 2018-01-09
US20040234474A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
DE60212847D1 (de) Topisch anwendbare arzneimittelformulierung
BR0107869A (pt) Composições farmacêuticas eletrogiradas
ID27504A (id) Formulasi oral baru
CL2009001279A1 (es) Compuestos derivados de nociceptina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor (sol. divisional 2103-03).
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
DE60105448D1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
EE05383B1 (et) Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon
HUP0302881A2 (hu) Legalább egy D-vitamint vagy D-vitamin analóg vegyületet és legalább egy kortikoszteroidot tartalmazó külsőleges gyógyszerkészítmények
HUP0300472A2 (hu) Topikális helyi érzéstelenítż alkalmazáshoz való intradermális penetrációs anyagok
IL159584A0 (en) Pharmaceutical formulation comprising a proton pump inhibitor and antacids
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
NO20024099L (no) Lavdose entecavir-formulering og anvendelse
IS7065A (is) Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð
ATE291914T1 (de) Zolmitriptanhaltige arzneizusammensetzungen
DE60019334D1 (de) Antivirale arznei
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
NO20040055L (no) Sarbandasje
DK1330258T3 (da) Kahalalid F-formulering
PL402550A1 (pl) Dopochwowe kompozycje farmaceutyczne oraz zastosowanie zródla nadtlenku i bioadhezyjnego nosnika
ATE491447T1 (de) Flavonoide und tocotrienole enthaltende zusammensetzungen und deren verwendungen
DE60024476D1 (de) Pedikulizide und veterinärmedizinische zusammensetzungen
SE0001916D0 (sv) Novel formulation
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
NO20031650D0 (no) Nye legemidler for leversykdommer
ATE298564T1 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten und einen netzmittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1409034

Country of ref document: EP